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Abstract
Objective—We sought to describe an emerging drug use pattern characterized by injection of 
both methamphetamine and heroin. We examined differences in drug injection patterns by 
demographics, injection behaviors, HIV and HCV status, and overdose.
Methods—Persons who inject drugs (PWID) were recruited as part of the National HIV 
Behavioral Surveillance (NHBS) system in Denver, Colorado. We used chi-square statistics to 
assess differences between those who reported only heroin injection, only methamphetamine 
injection, and combined heroin and methamphetamine injection. We used generalized linear 
models to estimate unadjusted and adjusted prevalence ratios to describe the association between 
drug injection pattern and reported nonfatal overdose in 2015. We also examined changes in the 
drug reported as most frequently injected across previous NHBS cycles from 2005, 2009, and 
2012.
Results—Of 592 participants who completed the survey in 2015, 173 (29.2%) reported only 
injecting heroin, 123 (20.8%) reported only injecting methamphetamine, and 296 (50.0%) reported 
injecting both drugs during the past 12 months. Injecting both heroin and methamphetamine was 
associated with a 2.8 (95% confidence interval: 1.7, 4.5) fold increase in reported overdose in the 
past 12 months compared with only injecting heroin. The proportion of those reporting 
methamphetamine as the most frequently injected drug increased from 2.1% in 2005 to 29.6% in 
2015 (p < 0.001).
Conclusions—The rapid increase in methamphetamine injection, and the emergence of 
combining methamphetamine with heroin, may have serious public health implications.
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In the United States, heroin use has increased significantly during the past decade (Jones, 
Logan, Gladden, & Bohm, 2015). Potential contributors to the rising rates of heroin use are 
increased availability and lower price. In addition to its lower price, an increase in heroin 
purity is also likely contributing to its increased use (U.S. Drug Enforcement 
Administration, 2016). In the Denver metropolitan area, we have also observed a steady 
increase in methamphetamine use over the past several years (Denver Office of Drug 
Strategy, 2015). Since 2011, all methamphetamine indicators including treatment 
admissions, hospital discharges, emergency department visits, calls to the poison center, 
forensic exhibits, and mortality rates have been on the rise in the Denver metropolitan area 
(National Drug Early Warning System, 2016).
In Colorado, heroin is predominately Mexican-sourced “black-tar” and brown powder 
heroin. The wholesale distribution of heroin in Denver is controlled almost exclusively by 
Mexican drug organizations. In recent years, the same Mexican cartels have also been 
producing higher purity methamphetamine and marketing methamphetamine and heroin 
together (Denver Office of Drug Strategy, 2015; U.S. Drug Enforcement Administration, 
2015). Two of the current article’s co-authors began learning about the increase in 
methamphetamine use and, in particular, its use among long time heroin users during the 
summer of 2013 while conducting ethnographic fieldwork (Koester & Langegger, 2015). 
Several patterns of use have been identified and include: mixing heroin and 
methamphetamine in the same solution and injecting together (referred to by PWID as 
“goofballs”); injecting methamphetamine and heroin separately at different times, often for 
the purposes of countering or intensifying the effects of the other drug; and alternating 
injecting of methamphetamine and heroin depending on what is more readily available.
To our knowledge, there has been little discussion of the combined use of heroin and 
methamphetamine in the scientific literature, and what does exist focuses on reports of 
“goofball” injection with one group in Seattle reporting prevalence ranging from 11% in 
2009 (Jenkins et al., 2011; Peavy et al., 2012) to 32.7% in 2013 (Cedarbaum & Banta-
Green, 2016). In a sample of PWID recruited in Los Angeles and San Francisco between 
2011 and 2013, the reported prevalence of “goofball” injection during the past 30 days was 
11% (Arreola et al., 2014; Bluthenthal et al., 2015). The earliest report of injection of heroin 
mixed with methamphetamine appears to be from a sample of young PWID recruited in San 
Francisco between 2000 and 2001. In this sample, 23% reported “goofball” injection (Ochoa 
et al., 2005). While there is little scientific literature describing this methamphetamine and 
heroin injection pattern, discussions about combining the two drugs can be found on 
websites that provide a forum for PWID to exchange information about drug use 
experiences. The combination of depressant and stimulant drugs puts the cardiovascular, 
respiratory, and central nervous systems under immense pressure to process different 
messages which can result in unpredictable outcomes. Given the dearth of information and 
the potential associated morbidity and mortality, we sought to quantify and describe this 
emerging heroin and methamphetamine injection pattern in a sample of PWID in Denver, 
Colorado.
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National HIV Behavioral Surveillance System
The National HIV Behavioral Surveillance (NHBS) system was established in 2003 by the 
Centers for Disease Control and Prevention (CDC) to monitor risk behaviors among three 
populations at highest risk for HIV infection in the United States: gay, bisexual, and other 
men who have sex with men, persons who inject drugs, and heterosexuals at increased risk 
for HIV. NHBS involves rotating 12-month cycles of surveillance activities in these three 
populations. Surveillance activities include ethnographic formative research, an in-depth 
behavioral survey, and HIV testing during each cycle. The analyses presented in the current 
article are from the 2015 NHBS cycle among PWID in Denver, Colorado. In addition, we 
examined one data point (i.e. most frequency injected drug) from previous NHBS cycles 
among PWID in 2005, 2009, and 2012.
Study design and protocol
Between June and December 2015, participants were recruited using respondent-driven 
sampling (RDS), a peer-referral sampling methodology (Heckathorn, 1997). In RDS, initial 
“seed” participants are identified through key stakeholders and are recruited for 
participation. Seeds are then asked to recruit persons from their networks using referral 
coupons, who in turn use coupons to recruit persons from their networks, and so on. Each 
eligible participant was allowed to refer up to five persons from their network. Participants 
were instructed to recruit someone they knew who injects drugs and who they had seen in 
the past 30 days. RDS employs a dual incentive structure, thus, participants were 
compensated for their participation in addition to being compensated a smaller amount for 
each eligible person they successfully recruited.
Persons were eligible to participate if they were at least 18 years or older, had injected drugs 
during the preceding 12 months, resided in the Denver metropolitan statistical area, had not 
previously participated in the 2015 NHBS cycle, and were able to provide informed consent. 
Additional eligibility criteria included having physical evidence of recent injection (fresh 
track marks) or having current knowledge of drug preparation and injection technique and 
syringe description.
Verbal informed consent was obtained from eligible participants. Participants completed a 
standardized interviewer-administered behavioral risk survey using handheld computers.
The behavioral risk survey includes questions about sexual behaviors, injection behaviors, 
substance use, and HIV testing. In addition to the behavioral risk survey, which is the core 
NHBS survey and administered nationally across all sites, participants completed a shorter 
local questionnaire. Local questionnaires are developed during the formative research phase 
of NHBS which includes interviews with key informants and focus groups to identify salient 
issue of concern or interest for the target population.
During the 2015 formative research phase, key informants confirmed the ethnographic report 
of a rising trend in the use of methamphetamine along with heroin. To address this issue we 
included a question in the local Denver questionnaire in which participants were asked if 
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they injected heroin only, methamphetamine only, or both during the past 12 months. 
Participants who reported injecting both were asked how they usually inject the drugs. 
Response options to this question were: inject them separately at different times of the day, 
inject them both at the same time by mixing and injecting them together (i.e. goofball), or 
inject them separately and together as goofballs. In the local questionnaire, participants were 
also asked about their overdose experience in the past 12 months. Overdose was not 
explicitly defined for participants.
Participants were also offered a rapid HIV test in addition to a rapid test for Hepatitis C 
Virus (HCV). Participants were given $35 for completing the survey, $35 for HIV and HCV 
testing, and $20 for each eligible person they recruited. All NHBS activities were voluntary 
and no names were collected. The study protocol was reviewed and approved by the 
Colorado Multiple Institutional Review Board.
The protocol for data collection was similar for the previous NHBS cycles among PWID in 
2005, 2009, and 2012.
Statistical analysis
Analysis of the 2015 NHBS data was restricted to 592 participants who had complete data 
on methamphetamine and heroin injection in the past 12 months. Chi-square (X2) statistics 
and Fisher’s exact tests were calculated to assess differences for categorical variables based 
on drug injection patterns (methamphetamine only, heroin only, both). We used generalized 
linear models with log link and binomial error distribution to estimate unadjusted and 
adjusted prevalence ratios (PR) and 95% confidence intervals (CI) to describe the 
association between drug injection patterns and overdose. Multivariate analysis was 
conducted to control for factors that could potentially confound the main association. All 
analyses were conducted using StataSE Version 12 (StataCorp, College Station, TX).
To examine trends in the drug reported as most frequently injected, we used the Cochran-
Armitage test for trend over multiple years. We examined evidence for or against a constant 
level of the proportion of those reporting a certain drug as the most frequently injected 
across time. Trend analysis was conducted using XLSTAT (Addinsoft, New York, NY).
Results
Trend in most frequently injected drug
Since 2005, the proportion of participants reporting methamphetamine as their most 
frequently injected drug has steadily increased from 2.1% in 2005 to 13.3% in 2009 to 
20.5% in 2012 to 29.6% in 2015 (p-value for Cochran-Armitage < 0.001; Figure 1). During 
that same time frame, the proportion of participants reporting heroin as their most frequently 
injected drug has fluctuated with 48.4% in 2005 to 72.4% in 2009 to 62.4% in 2012 and 
58.4% in 2015. The proportion of participants reporting cocaine as their most frequently 
injected drug steadily decreased from 21.8% in 2005 to 2.7% in 2015 (p-value for Cochran-
Armitage = 0.005).
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Characteristics of the 2015 NHBS study population
A total of 710 persons were screened for the 2015 cycle of NHBS in Denver, of whom 609 
(85.8%) were eligible to participate and 592 (83.4%) completed the local questionnaire. The 
final sample included 19 (3.2%) seed participants, all of whom were 29 years or younger. 
Younger seeds were purposefully recruited in an attempt to generate a sample which more 
accurately represents the PWID population. Approximately three quarters (71.4%) of 
participants were male and more than half (58.8%) identified as non-Hispanic white (Table 
1). Nearly one-quarter (22.1%) were 29 years or younger. A large proportion of participants 
reported experiencing homelessness with 67.1% reporting being currently homeless and 
14.7% reporting being homeless, but not in the past 12 months. Among male participants, 53 
(12.6%) reported having oral or anal sex with a man in the past 12 months.
Heroin and methamphetamine injection
Approximately half of the participants reported injecting both heroin and methamphetamine 
during the past 12 months (Table 1). When asked about the usual method of injection, 130 
(43.9%) reported injecting the drugs separately at different times, 83 (28.0%) reported 
mixing the drugs together and injecting (this is called a “goof-ball”), and 71 (24.0%) 
reported doing both (data not shown). Participants who reported injecting both heroin and 
methamphetamine were significantly more likely to be white, non-Hispanic, younger, 
currently homeless, and report knowing larger numbers of other PWID that they have seen 
in the past 30 days.
Injection characteristics
Overall, 7.3% of participants were recent injectors reporting that their first injection was 
within the past year (Table 2). A total of 244 (41.2%) participants reported heroin as the first 
drug they ever injected while 176 (29.7%) reported methamphetamine as their first injected 
drug. Nearly 80% of participants reported injecting once or more than once a day. 
Participants who reported injecting both heroin and methamphetamine (79.7%) were 
significantly more likely to report injecting more than once a day compared to those only 
injecting heroin and those only injecting methamphetamine, 61.9% and 45.5%, respectively. 
Participants who reported injecting heroin and methamphetamine were also more likely to 
report reusing syringes. In addition, those who reported injecting both heroin and 
methamphetamine were more likely to report sharing a syringe at least once in the past 12 
months but less likely to report sharing water, cookers, or cottons (Table 2).
HIV/HCV infection
A total of 341 (60.5%) participants were infected with HCV and 21 (3.6%) were infected 
with HIV (Table 3). Among participants who were HIV infected, the proportion was higher 
among those who reported injecting methamphetamine only (11.1%) compared to those who 
reported injecting both methamphetamine and heroin (2.0%). Among participants who were 
HCV infected, the proportion was higher among those who reported injecting heroin only 
(67.9%) compared to those who reported injecting both (63.7%).
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Nearly two-thirds (63.9%) of participants reported visiting a syringe access program during 
the past 12 months (Table 3). Participants who reported injecting both heroin and 
methamphetamine were significantly more likely to report visiting a syringe access program 
compared to those reporting methamphetamine injection only and those who reported heroin 
injection only. In addition, those reporting heroin and methamphetamine injection were 
more likely to report receiving a naloxone kit in the past 12 months.
Overdose
Participants who reported injecting both heroin and methamphetamine were significantly 
more likely to report overdosing in the past 12 months with 18.6% reporting overdosing 
once and 15.2% reporting overdosing two or more times during the past 12 months (Table 
3). Among those who reported injecting both drugs, we examined reported overdose by the 
usual method of injection. Participants who reported that they injected the drugs separately 
at different times were slightly more likely to report at least one overdose in the past 12 
months compared to those who reported mixing the drugs and then injecting and those 
reporting both methods, 38.9% vs. 20.7% and 38.0%, respectively (p = 0.015). After 
adjusting for race/ethnicity, age, frequency of injection, being held in a detention center, jail, 
or prison for more than 24 hours in the past 12 months, and homelessness, injecting both 
heroin and methamphetamine was associated with a 2.8 (95% confidence interval: 1.7, 4.5) 
fold increase in the risk of overdose in the past 12 months compared with only injecting 
heroin (Table 4).
Discussion
In Denver, a growing number of PWID are injecting both heroin and methamphetamine. To 
date, only a handful of studies have reported a similar phenomenon (Bluthenthal et al., 2015; 
Cedarbaum & Banta-Green, 2016; Ochoa et al., 2005; Peavy et al., 2012). However, these 
studies only reported the use of goofballs, the injection of both drugs simultaneously in a 
single shot, or injected separately during the same injection episode. PWID may also 
consider injecting heroin and smoking methamphetamine, another form of goofball. Our 
results indicate that, while common, goofballs are but one way these two drugs are used in 
concert. While 28% of participants reported injecting goofballs, more than 40% reported 
injecting both drugs, but at separate times, and a quarter of participants reported injecting 
goofballs and injecting the drugs separately.
Increasingly, methamphetamine use and the primary methamphetamine indicators used by 
the Community Epidemiology Work Groups across the 20 representative regions appear to 
be on the rise in the Western United States (National Institute on Drug Abuse, 2014). 
Reporting an exhaustive analysis of data sources, including drug trafficking data from the 
US Drug Enforcement Agency, drug treatment admissions data, drug-treated emergency 
department visits, and arrestee drug monitoring data, Pollini and Strathdee documented a 
substantial increase in the use of methamphetamine in San Diego County, California 
between 2001 and 2005 (Pollini & Strathdee, 2007). However, less is known about poly-
drug use in markets dominated by black tar heroin and methamphetamine, such as the 
Al-Tayyib et al. Page 6













Southwestern United States. A more recent latent class analysis explored polydrug use 
among PWID in San Diego to examine habitual drug use to identify distinct patterns of 
heroin and methamphetamine mixing in a drug market that is characterized predominantly 
by black tar heroin and methamphetamine (Roth et al., 2015). While this study identified 
characteristics of two distinct classes of drug use, primarily methamphetamine users with 
multiple routes of administration and primarily heroin injectors, simultaneous injection of 
methamphetamine and heroin were excluded from the analysis. A second latent class 
analysis to identify classes of polydrug use among heroin users in Tijuana, Mexico, 
concluded that a majority of individuals who use both heroin and methamphetamine report a 
simultaneous injection of these substances (Meacham et al., 2015). The study authors also 
found the injection of heroin and methamphetamine together was significantly associated 
with receptive and distributive syringe sharing, marginally associated with both overdose 
and drug use before. Identifying another heroin and methamphetamine drug use pattern in 
San Francisco, California, Harris and colleagues found that both injected and noninjected 
methamphetamine use was more prevalent among people who inject heroin infrequently, 
suggesting that this group comprises primary methamphetamine users who use heroin to 
come “down” from methamphetamine (Harris et al., 2013).
Our results showing that PWID who used both heroin and methamphetamine in Denver were 
more likely to be homeless supports the finding of recent ethnographic research describing 
an increase in methamphetamine use among homeless heroin injectors and linking it, in part, 
to the city’s new ordinances that control the use of public space (Langegger & Koester, 
2016a, 2016b). In 2012, the city passed a camping ban rendering it illegal to dwell 
“temporarily in a place, with shelter.” The ordinance goes on to define dwelling as 
conducting activities such as eating, sleeping and the storage of personal possessions. The 
wording of the ban describes shelter as: “any tent, tarpaulin, lean-to, sleeping bag, bedroll, 
blankets, or any other form of protection from the elements other than clothing.” In the City 
of Denver, sleeping in public space is no longer an option. Resting with ‘shelter’ now 
violates municipal code. Shelters are an option. However, for undomiciled persons, many of 
whom see shelters as patronizing, crowded, and often dangerous places, the option of using 
homeless shelters is less preferable than being on the street. Consequently, incessant motion 
and staying awake become viable options for avoiding interactions with the police and/or 
being cited for violating the camping ban (Hopper & Barrow, 2003). Methamphetamine 
provides homeless PWID with a pharmacological aid for responding to this structurally 
imposed risk environment (Koester, Langegger, & Al-Tayyib, 2016).
The combined use of methamphetamine and heroin may have important implications for 
blood-borne disease transmission and overdose. Injecting both drugs was associated with 
more injection risk and knowing large numbers of other PWID. Participants who use both 
drugs were significantly more likely to inject multiple times per day compared to PWID who 
reported injecting either heroin or methamphetamine only. They were also more likely to 
report syringe reuse as well as sharing a syringe at least once in the past 12 months. PWID 
who injected both drugs reported knowing larger numbers of other PWID that they had seen 
in the past 30 days suggesting that they may have larger and more open drug using networks. 
Fortunately, PWID who reported the use of both drugs were more likely to use the services 
of the city’s two syringe access programs.
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Although studies have found associations between overdose and polydrug use trends 
combining heroin with sedatives, and heroin with cocaine, the literature on the potential link 
between overdose and the combined use of heroin and methamphetamine is sparse at best. 
One study on nonfatal overdose in Seattle found an association with goofball injecting in 
bivariate analysis, however, in multivariate analysis, only recent incarceration and sharing 
injection paraphernalia remained significantly associated with overdose (Jenkins et al., 
2011). Another study of overdose in San Francisco found injection of heroin mixed with 
methamphetamine in the past 3 months to be an independent predictor of overdose (Ochoa et 
al., 2005). Our results indicate the association between nonfatal overdose and the combined 
use of methamphetamine and heroin is not limited to the injection of goofballs but includes 
other patterns of combined use including injecting the drugs separately at different times of 
the day. Just over a third of participants who inject both heroin and methamphetamine 
reported overdosing at least once in the past 12 months, with 15% reporting that they 
overdosed more than once. Data from the Office of the Denver Medical Examiner provides 
additional evidence for a link between the combined use of heroin and methamphetamine 
and overdose. There was a fourfold increase in deaths involving both heroin and 
methamphetamine from 4 in 2005 to 16 in 2015 (J. Caruso, personal communication, May 
12, 2016).
Our findings are subject to several limitations. First, some participants might not have 
reported their behaviors accurately due to the survey being administered by an interviewer. 
Second, while we did perform confirmatory testing for those with a reactive rapid HIV test, 
we did not run RNA tests on samples from participants who were HCV antibody positive so 
our HCV numbers may include individuals who have cleared the infection. Third, though 
participants were recruited using RDS, we do not present RDS-weighted estimates. Fourth, 
the study was a cross-sectional survey therefore causality cannot be inferred. Finally, our 
results are limited to respondents in one urban city and may not be generalizable to PWID in 
other parts of the United States.
Conclusion
It seems surprising that the combined use of heroin and methamphetamine has not received 
more attention. At least in the case of Denver, it has become a predominant drug pattern, 
particularly among homeless PWID. As our results indicate, the combination of heroin and 
methamphetamine involves more than goofball injecting and appears to have important 
public health implications, including increased risk of overdose. We would suggest that this 
drug use pattern merits further research including research on the factors that drive it, the 
forms of use it includes, and the potential health concerns it raises.
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Most frequently injected drug among persons who inject drugs. Source: National HIV 
Behavioral Surveillance, Denver, Colorado, 2005–2015.
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Table 4
Association between overdose and drug injection pattern in the past 12 months in a sample of persons who 
inject drugs.
Overdosed at least once
n (%)
Unadjusted prevalence ratio 
(95% CI)
Adjusted prevalence ratio* (95% 
CI)
Drug injection pattern
 Heroin only 20 (11.6)   1.0 (ref)   1.0 (ref)
 Methamphetamine only 9 (7.4) 0.63 (0.30,1.35) 0.64 (0.29, 1.43)
 Both heroin and methamphetamine 99 (33.6) 2.89 (1.85,4.49) 2.80 (1.72,4.53)
Source: National HIV Behavioral Surveillance (NHBS), Denver, Colorado, 2015.
*
Adjusted for race/ethnicity, age, frequency of injection, incarceration, and homelessness.
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